Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00277472
Status:
COMPLETED
Last Update Posted:
2011-06-07
First Post:
2006-01-12
Brief Title:
Efficacy and Safety of ValsartanHydrochlorothiazide Combination Therapy in Patients With Hypertension
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 28-week Multicenter Study to Evaluate the Effects of ValsartanHydrochlorothiazide 160125 mg in Comparison With Hydrochlorothiazide 25 mg Monotherapy for the Treatment of Patients With Hypertension Uncontrolled by Hydrochlorothiazide 125 mg Monotherapy
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the efficacy and safety of valsartanhydrochlorothiazide combination therapy in patients with hypertension not controlled with hydrochlorothiazide monotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None